Prostatic Neoplasms Active Not Recruiting Phase 1 / 2 Trials for Cabozantinib (DB08875)

Also known as: Neoplasm,Prostatic / Neoplasms, Prostatic / Prostatic Neoplasm

IndicationStatusPhase
DBCOND0028225 (Prostatic Neoplasms)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01683994Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate CancerTreatment